Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors

Molecular Immunology

Volumn 45, Issue 1, 2008, Pages 169-179

  Okroj, Marcin ^a   Hsu, Yi Fan ^b   Ajona, Daniel ^b   Pio, Ruben ^b,c   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Complement; Cytotoxicity; Immune system; NSCLC; Tumor

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR I; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA;

ARTICLE; CANCER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; LYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; COMPLEMENT ACTIVATION; COMPLEMENT C3B; COMPLEMENT C4B; COMPLEMENT FACTOR I; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LUNG NEOPLASMS; PROTEIN BINDING; RNA, MESSENGER; SOLUBILITY;

EID: 34548288545     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2007.04.025     Document Type: Article

References (36)

1. Ajona D., Castano Z., Garayoa M., Zudaire E., Pajares M.J., Martinez A., Cuttitta F., Montuenga L.M., and Pio R. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res. 64 (2004) 6310-6318
2. Allegretti M., Moriconi A., Beccari A.R., Di Bitondo R., Bizzarri C., Bertini R., and Colotta F. Targeting C5a: recent advances in drug discovery. Curr. Med. Chem. 12 (2005) 217-236
3. Blom A.M., Kask L., and Dahlbäck B. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276 (2001) 27136-27144
4. Blom A.M., Kask L., and Dahlbäck B. CCP1-4 of the C4b-binding protein α-chain are required for Factor I mediated cleavage of C3b. Mol. Immunol. 39 (2003) 547-556
5. Blom A.M., Rytkönen A., Vasquez P., Lindahl G., Dahlbäck B., and Jonsson A.-B. A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4b-binding protein. J. Immunol. 166 (2001) 6764-6770
6. Blom A.M., Villoutreix B.O., and Dahlback B. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch. Immunol. Ther. Exp. (Warsz) 52 (2004) 83-95
7. Budzko D.B.L.P., and McConnell I. Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis. Cell Immunol. 22 (1976) 98-109
8. Crossley L., and Porter R. Purification of the human complement control protein C3b inactivator. Biochem. J. 191 (1980) 173-182
9. Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem. J. 209 (1983) 847-856
10. Donin N., Jurianz K., Ziporen L., Schultz S., Kirschfink M., and Fishelson Z. Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid. Clin. Exp. Immunol. 131 (2003) 254-263
11. Elward K., Griffiths M., Mizuno M., Harris C.L., Neal J.W., Morgan B.P., and Gasque P. CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J. Biol. Chem. 280 (2005) 36342-36354
12. Fishelson Z., Donin N., Zell S., Schultz S., and Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol. Immunol. 40 (2003) 109-123
13. Fujita T.T.S., Kodama N., Matsushita M., and Fujita T. Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway. Jpn. J. Cancer Res. 86 (1995) 187-192
14. Gasque P., Julen N., Ischenko A.M., Picot C., Mauger C., Chauzy C., Ripoche J., and Fontaine M. Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149 (1992) 1381-1387
15. Gorter A., and Meri S. Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol. Today 20 (1999) 576-582
16. Hakulinen J., Junnikkala S., Sorsa T., and Meri S. Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form. Eur. J. Immunol. 34 (2004) 2620-2629
17. Ikuta K.T.K., Kihara M., Naito S., Lee E., Shimizu E., and Yamauchi A. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Oncol. Rep. 13 (2005) 1229-1234
18. Jemal A., Thomas A., and Murray T.M.T. Cancer statistics. CA Cancer J. Clin. 52 (2002) 23-47
19. Jurianz K., Ziegler S., Garcia-Schuler H., Kraus S., Bohana-Kashtan O., Fishelson Z., and Kirschfink M. Complement resistance of tumor cells: basal and induced mechanisms. Mol. Immunol. 36 (1999) 929-939
20. Kask L., Hillarp A., Ramesh B., Dahlbäck B., and Blom A.M. Structural requirements for the intra-cellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 41 (2002) 9349-9357
21. Kask L., Trouw L., Dahlbäck B., and Blom A.M. C4b-binding protein-protein S complex inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 279 (2004) 23869-23873
22. Legoedec J., Gasque P., Jeanne J.F., and Fontaine M. Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I. Eur. J. Immunol. 25 (1995) 3460-3466
23. Manches O., Lui G., Chaperot L., Gressin R., Molens J.P., Jacob M.C., Sotto J.J., Leroux D., Bensa J.C., and Plumas J. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood 101 (2003) 949-954
24. Minta J.O., Fung M., and Paramaswara B. Transcriptional and post-transcriptional regulation of complement factor I (CFI) gene expression in Hep G2 cells by interleukin-6. Biochim. Biophys. Acta 1442 (1998) 286-295
25. Munn L.L. Aberrant vascular architecture in tumors and its importance in drug-based therapies. Drug Discov. Today 8 (2003) 396-403
26. Murdoch C., Giannoudis A., and Lewis C.E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104 (2004) 2224-2234
27. Schlaf G., Demberg T., Beisel N., Schieferdecker H.L., and Gotze O. Expression and regulation of complement factors H and I in rat and human cells: some critical notes. Mol. Immunol. 38 (2001) 231-239
28. Sim R.B., and Laich A. Serine proteases of the complement system. Biochem. Soc. Trans. 28 (2000) 545-550
29. Stern M.H.R. Overview of monoclonal antibodies in cancer therapy: present and promise. Crit. Rev. Oncol. Hematol. 54 (2005) 11-29
30. Trouw L.A., Nilsson S.C., Goncalves I., Landberg G., and Blom A.M. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201 (2005) 1937-1948
31. Tsiftsoglou S.A., and Sim R.B. Human complement factor I does not require cofactors for cleavage of synthetic substrates. J. Immunol. 173 (2004) 367-375
32. Ullman C.G., Chamberlain D., Ansari A., Emery V.C., Haris P.I., Sim R.B., and Perkins S.J. Human complement factor I: its expression by insect cells and its biochemical and structural characterisation. Mol. Immunol. 35 (1998) 503-512
33. Varsano S.R.L., Shapiro H., Ophir D., and Mark-Bentankur T. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance. Clin. Exp. Immunol. 113 (1998) 173-182
34. Vetvicka V., Reed W., Hoover M.L., and Ross G.D. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J. Immunol. 150 (1993) 4052-4060
35. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
36. Webb J.H., Blom A.M., and Dahlbäck B. Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J. Immunol. 169 (2002) 2580-2586